Liraglutide attenuates obese-associated breast cancer cell proliferation via inhibiting PI3K/Akt/mTOR signaling pathway

Alaa Alanteet; Hala Attia; Musaed Alfayez; Amer Mahmood; Khalid Alsaleh; Sary Alsanea

doi:10.1016/j.jsps.2023.101923

Citations

389

Views

Abstract not available for this publication.

Cite this Article (APA)

Alaa, A., Hala, A., Musaed, A., Amer, M., Khalid, A., Sary, A. (2024). Liraglutide attenuates obese-associated breast cancer cell proliferation via inhibiting PI3K/Akt/mTOR signaling pathway. Saudi Pharmaceutical Journal. https://doi.org/10.1016/j.jsps.2023.101923

Devesh U. Kapoor; Rahul Garg; Mansi Gaur; Ashutosh Pareek; Bhupendra G. Prajapat · 2024

cites

397

Exploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A r…

Preeti; Sharda Sambhakar; Renu Saharan; Sonia Narwal; Rohit Malik; Vinod Gahlot; · 2023

cites

396

Exploring the synthesis, structure, spectroscopy and biological activities of novel 4-benzylidene-1-…

Mahnoor Waheed; Sana Idris; Faheem Jan; Aftab Alam; Aftab Alam; Muhammad Ibrahim · 2023

cites

395

Plant-mediated green synthesis of gold nanoparticles using an aqueous extract of Passiflora ligulari…